Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147517

1.

Prostate cancer screening: guidelines review and laboratory issues.

Filella X, Albaladejo MD, Allué JA, Castaño MA, Morell-Garcia D, Ruiz MÀ, Santamaría M, Torrejón MJ, Giménez N.

Clin Chem Lab Med. 2019 May 23. pii: /j/cclm.ahead-of-print/cclm-2018-1252/cclm-2018-1252.xml. doi: 10.1515/cclm-2018-1252. [Epub ahead of print] Review.

PMID:
31120856
2.

Dynamic Contrast-Enhanced MRI-Upgraded Prostate ImagingReporting and Data System Version 2 Category 3 Peripheral Zone Observations Stratified by a Size Threshold of 15 mm.

Abreu-Gomez J, Krishna S, Narayanasamy S, Flood TA, McInnes MDF, Schieda N.

AJR Am J Roentgenol. 2019 May 23:1-8. doi: 10.2214/AJR.18.21005. [Epub ahead of print]

PMID:
31120786
3.

Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.

Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami SS, Kishan AU, Wang C, Schaeffer EM, Roach M 3rd, Pisansky TM, Shipley WU, Freedland SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, Spratt DE.

JAMA Oncol. 2019 May 23. doi: 10.1001/jamaoncol.2019.0826. [Epub ahead of print]

PMID:
31120534
4.

Racial Inequality in Prostate Cancer Outcomes-Socioeconomics, Not Biology.

Paller CJ, Wang L, Brawley OW.

JAMA Oncol. 2019 May 23. doi: 10.1001/jamaoncol.2019.0812. [Epub ahead of print] No abstract available.

PMID:
31120499
5.

[Robot-assisted radical prostatectomy - functional result. Part II].

Pushkar DY, Kolontarev KB.

Khirurgiia (Mosk). 2019;(4):80-86. doi: 10.17116/hirurgia201904180. Russian.

PMID:
31120453
6.
7.

Caspase-Dependent Apoptosis in Prostate Cancer Cells and Zebrafish by Corchorusoside C from Streptocaulon juventas.

Anaya-Eugenio GD, Addo EM, Ezzone N, Henkin JM, Ninh TN, Ren Y, Soejarto DD, Kinghorn AD, Carcache de Blanco EJ.

J Nat Prod. 2019 May 23. doi: 10.1021/acs.jnatprod.9b00140. [Epub ahead of print]

PMID:
31120251
8.

NES1/KLK10 and hNIS gene therapy enhanced iodine-131 internal radiation in PC3 proliferation inhibition.

Hu J, Shen W, Qu Q, Fei X, Miao Y, Huang X, Liu J, Wu Y, Li B.

Front Med. 2019 May 22. doi: 10.1007/s11684-018-0643-y. [Epub ahead of print]

PMID:
31119602
9.

Prehabilitation and acute postoperative physical activity in patients undergoing radical prostatectomy: a secondary analysis from an RCT.

Au D, Matthew AG, Lopez P, Hilton WJ, Awasthi R, Bousquet-Dion G, Ladha K, Carli F, Santa Mina D.

Sports Med Open. 2019 May 22;5(1):18. doi: 10.1186/s40798-019-0191-2.

PMID:
31119491
10.

PET imaging of hepatocellular carcinoma with anti-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in comparison with L-[S-methyl-11C]methionine.

Sergeeva O, Zhang Y, Kenyon JD, Miller-Atkins GA, Wu C, Iyer R, Sexton S, Wojtylak P, Awadallah A, Xin W, Chan ER, O'Donnel JK, Lee Z.

EJNMMI Res. 2019 May 22;9(1):47. doi: 10.1186/s13550-019-0519-4.

PMID:
31119488
11.

Comparison of longitudinal health-related quality-of-life outcomes between anterior and posterior surgical approaches to robot-assisted radical prostatectomy.

Maruyama Y, Sadahira T, Araki M, Mitsui Y, Wada K, Tanimoto R, Kobayashi Y, Watanabe M, Watanabe T, Nasu Y.

J Robot Surg. 2019 May 22. doi: 10.1007/s11701-019-00975-6. [Epub ahead of print]

PMID:
31119473
12.

Vasectomy and prostate cancer risk: a 38-year nationwide cohort study.

Husby A, Wohlfahrt J, Melbye M.

J Natl Cancer Inst. 2019 May 23. pii: djz099. doi: 10.1093/jnci/djz099. [Epub ahead of print]

PMID:
31119294
13.

Is vasectomy a cause of prostate cancer?

Mucci LA, Wilson KM, Preston MA, Giovannucci EL.

J Natl Cancer Inst. 2019 May 23. pii: djz102. doi: 10.1093/jnci/djz102. [Epub ahead of print] No abstract available.

PMID:
31119274
14.

68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy.

Tan JSH, Goh CXY, Koh YS, Li Y, Tuan JKL, Chua ET, Tan TWK, Wang MLC, Lee LS, Tay KJ, Kanesvaran R, Toh CK, Tong AKT, Lam WWC, Chua MLK.

Cancer Biol Med. 2019 Feb;16(1):157-166. doi: 10.20892/j.issn.2095-3941.2018.0288.

PMID:
31119056
15.

Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy.

Kozikowski M, Zagożdżon B, Gola M, Dobruch J.

Wideochir Inne Tech Maloinwazyjne. 2019 Apr;14(2):262-270. doi: 10.5114/wiitm.2019.83869. Epub 2019 Mar 26.

PMID:
31118993
16.

A new predictor is comparable to the updated nomogram in predicting the intermediate- and high-risk prostate cancer but outperforms nomogram in reducing the overtreatment for the low-risk Pca.

Wang H, Tai S, Zhang L, Zhou J, Liang C.

Cancer Manag Res. 2019 Apr 30;11:3753-3763. doi: 10.2147/CMAR.S194258. eCollection 2019.

PMID:
31118794
17.

RRBP1 is highly expressed in prostate cancer and correlates with prognosis.

Li T, Wang Q, Hong X, Li H, Yang K, Li J, Lei B.

Cancer Manag Res. 2019 Apr 23;11:3021-3027. doi: 10.2147/CMAR.S186632. eCollection 2019.

PMID:
31118771
18.

CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p.

Cai C, Zhi Y, Wang K, Zhang P, Ji Z, Xie C, Sun F.

Onco Targets Ther. 2019 May 2;12:3363-3372. doi: 10.2147/OTT.S196931. eCollection 2019.

PMID:
31118688
19.

Altered circulating levels of adipokine omentin-1 in patients with prostate cancer.

Zhou L, He W, Wang W, Zhou D.

Onco Targets Ther. 2019 May 1;12:3313-3319. doi: 10.2147/OTT.S197507. eCollection 2019.

PMID:
31118682
20.

Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats.

Al-Trad B, Aljabali A, Al Zoubi M, Shehab M, Omari S.

Int J Nanomedicine. 2019 May 3;14:3145-3154. doi: 10.2147/IJN.S202645. eCollection 2019.

PMID:
31118628

Supplemental Content

Loading ...
Support Center